Composition for treating diabetes

Abstract

The invention provides a composition for treating diabetes, and belongs to the technical field of medicines. The composition comprises the following components in percentage by mass: 5%-60% of beta-nicotinamide mononucleotide, 5%-60% of chromium-enriched yeast, 5%-60% of selenium-enriched yeast, 5%-60% of agaricus blazei murill polysaccharide and 5%-60% of coenzyme Q10. The preparation method comprises the following steps: uniformly mixing the components, and conducting encapsulating or tabletting to obtain the traditional Chinese medicine composition. The composition for treating diabetes mellitus provided by the invention can activate insulin activity, treat and prevent various types of diabetes mellitus, prevent and assist in treating various tumors, inhibit viruses, improve the immunity of the organism, strengthen the heart, nourish the liver, regulate blood pressure, beautify and shape the body, and delay senescence.

Description

technical field

[0001] The invention relates to a composition for treating diabetes and belongs to the technical field of medicine. Background technique

[0002] Diabetes is a group of metabolic diseases characterized by hyperglycemia. Hyperglycemia is due to defective insulin secretion or impaired biological action, or both. Long-term hyperglycemia leads to chronic damage and dysfunction of various tissues, especially the eyes, kidneys, heart, blood vessels, and nerves.

[0003] Diabetes is a global epidemic, with a dramatic increase in the number of patients. The prevalence of diabetes in my country has increased from 0.67% in early 1980 to 9.7% in 2008. In the past 30 years, the prevalence has increased by 13 times. According to the diabetes map released by the International Diabetes Federation (IDF) in 2017, nearly 425 million people worldwide suffer from diabetes in 2017, of which 80% are in low- and middle-income countries, and one-third are elderly people over the ...

Examples

preparation example Construction

[0055] A composition for treating diabetes and a preparation method thereof provided by the present invention include the following components in mass percent: 5% to 60% of NMN (beta-nicotinamide mononucleotide), 5% of chromium-rich yeast ~60%, selenium-enriched yeast 5%~60%, Agaricus blazei polysaccharide 5%~60%, coenzyme Q105%~60%.

[0056] In the present invention, the product for treating diabetes includes NMN (β-nicotinamide mononucleotide) with a mass percentage of 5% to 60%, more preferably 5% to 45%, and even more preferably 10%.

[0057] In the present invention, the diabetes treatment product includes chromium-rich yeast with a mass percentage of 5% to 60%, more preferably 35%, and still more preferably 10%.

[0058] In the present invention, the diabetes treatment product includes selenium-enriched yeast with a mass percentage of 5% to 60%, more preferably 5% to 45%, and even more preferably 15%.

[0059] In the present invention, the diabetes treatment product inc...

Embodiment 1

[0064] A composition for the treatment of diabetes, consisting of components of the following qualities:

[0065] NMN (β-nicotinamide mononucleotide) 150g, chromium-enriched yeast 250g, selenium-enriched yeast 250g, Agaricus blazei polysaccharide 250g, coenzyme Q10 100g. The above-mentioned raw materials are purchased from domestic production enterprises that meet product industry standards and specifications. Make 1000g, 2000 grains of this product.

[0066] Preparation method: mix all the components evenly, pack into capsules or compress into tablets, and obtain.

Embodiment 2

[0068] A composition for the treatment of diabetes, consisting of components of the following qualities:

[0069] NMN (β-nicotinamide mononucleotide) 200g, chromium-enriched yeast 200g, selenium-enriched yeast 200g, Agaricus blazei polysaccharide 200g, coenzyme Q10 200g. The above-mentioned raw materials are purchased from domestic production enterprises that meet product industry standards and specifications. Make 1000g, 2000 grains of this product.

[0070] Raw material source and preparation method are the same as embodiment 1.

technical field

[0001] The invention relates to a composition for treating diabetes and belongs to the technical field of medicine. Background technique

[0002] Diabetes is a group of metabolic diseases characterized by hyperglycemia. Hyperglycemia is due to defective insulin secretion or impaired biological action, or both. Long-term hyperglycemia leads to chronic damage and dysfunction of various tissues, especially the eyes, kidneys, heart, blood vessels, and nerves.

[0003] Diabetes is a global epidemic, with a dramatic increase in the number of patients. The prevalence of diabetes in my country has increased from 0.67% in early 1980 to 9.7% in 2008. In the past 30 years, the prevalence has increased by 13 times. According to the diabetes map released by the International Diabetes Federation (IDF) in 2017, nearly 425 million people worldwide suffer from diabetes in 2017, of which 80% are in low- and middle-income countries, and one-third are elderly people over the ...

Examples

preparation example Construction

[0055] A composition for treating diabetes and a preparation method thereof provided by the present invention include the following components in mass percent: 5% to 60% of NMN (beta-nicotinamide mononucleotide), 5% of chromium-rich yeast ~60%, selenium-enriched yeast 5%~60%, Agaricus blazei polysaccharide 5%~60%, coenzyme Q105%~60%.

[0056] In the present invention, the product for treating diabetes includes NMN (β-nicotinamide mononucleotide) with a mass percentage of 5% to 60%, more preferably 5% to 45%, and even more preferably 10%.

[0057] In the present invention, the diabetes treatment product includes chromium-rich yeast with a mass percentage of 5% to 60%, more preferably 35%, and still more preferably 10%.

[0058] In the present invention, the diabetes treatment product includes selenium-enriched yeast with a mass percentage of 5% to 60%, more preferably 5% to 45%, and even more preferably 15%.

[0059] In the present invention, the diabetes treatment product inc...

Embodiment 1

[0064] A composition for the treatment of diabetes, consisting of components of the following qualities:

[0065] NMN (β-nicotinamide mononucleotide) 150g, chromium-enriched yeast 250g, selenium-enriched yeast 250g, Agaricus blazei polysaccharide 250g, coenzyme Q10 100g. The above-mentioned raw materials are purchased from domestic production enterprises that meet product industry standards and specifications. Make 1000g, 2000 grains of this product.

[0066] Preparation method: mix all the components evenly, pack into capsules or compress into tablets, and obtain.

Embodiment 2

[0068] A composition for the treatment of diabetes, consisting of components of the following qualities:

[0069] NMN (β-nicotinamide mononucleotide) 200g, chromium-enriched yeast 200g, selenium-enriched yeast 200g, Agaricus blazei polysaccharide 200g, coenzyme Q10 200g. The above-mentioned raw materials are purchased from domestic production enterprises that meet product industry standards and specifications. Make 1000g, 2000 grains of this product.

[0070] Raw material source and preparation method are the same as embodiment 1.

Images